Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Ileana Vázquez-OteroNicolle Medina-CintrónMariangelí Arroyo-ÁvilaLorena González-SepúlvedaLuis M ViláPublished in: Lupus science & medicine (2021)
This study suggests that adjustment of daily HCQ dose to ≤5.0 mg/kg/day of actual body weight does not have a significant impact on the short-term and mid-term outcomes in this group of patients with SLE.